CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
Titel:
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
Auteur:
He, W. Eriksson, M. Eliasson, E. Grassmann, F. Bäcklund, M. Gabrielson, M. Hammarström, M. Margolin, S. Thorén, L. Wengström, Y. Borgquist, S. Hall, P. Czene, K.